FREE Shippingto US, AU, UK and EU on all orders over $149
/

Retinalamin® 5 mg, 10 amps lyophilized powder for intramuscular solution

$200.00

fadcf3376066
Brands

Description

The instruction for medical use
of RETINALAMIN® medicine

the Trade
name Retinalamin®

the International unlicensed name Is not present

the Dosage form Lyophilisate for preparation of solution for intramuscular and parabulbar introduction of 5 mg

Structure
1 bottle contains
active agent – retinalamin (a complex of the water-soluble polypeptide fractions allocated from extract of dry Retinalamin®) 5 mg,
excipient – glycine.

The description
the Lyophilized powder or porous mass of color, white or white with a yellowish shade,

Pharmacotherapeutic group
Drugs for treatment of a disease of eyes
Drugs for treatment of a disease of eyes other
the ATX S01XA Code

the Pharmacological

RETINALAMIN Pharmacodynamics properties – a complex of water-soluble polypeptide fractions with a molecular weight no more than 10,000 Yes.
Drug has promoting effect on photoreceptors and cellular elements of a retina, promotes improvement of functional interaction of a pigmentary epithelium and external segments of photoreceptors, glial cells at dystrophic changes, accelerates recovery of light sensitivity of a retina. Normalizes permeability of vessels, reduces manifestations of local inflammatory reaction, stimulates reparative processes in diseases and injuries of a retina of an eye.
The mechanism of action РЕТИНАЛАМИНА® is defined by its metabolic activity: drug improves metabolism of tissues of eye and normalizes functions of cellular membranes, improves intracellular synthesis of protein, regulates processes of peroxide oxidation of lipids, promotes optimization of power processes.
The pharmacokinetics
Structure РЕТИНАЛАМИНА® which active ingredient is a complex of polypeptide fractions does not allow to carry out the usual pharmacokinetic analysis of its separate components.

Indications
as a part of complex treatment of diseases:
– the compensated primary open angle glaucoma
– a diabetic retinopathy
– the central dystrophy of a retina of inflammatory and traumatic
genesis
– the central dystrophy of a retina
– a miopichesky disease
– the central and peripheral tapetoretinalny abiotrophy

the Route of administration and doses
In a diabetic retinopathy, the central dystrophy of a retina of inflammatory and traumatic genesis, the central and peripheral tapetoretinalny abiotrophy parabulbarno or intramusculary on 5 – 10 mg of 1 times a day. A course of treatment – 5-10 days, if necessary repeat in 3 – 6 months.
At the compensated primary open angle glaucoma parabulbarno or intramusculary on 5 mg of 1 times a day. A course of treatment – 10 days, if necessary repeat in 3 – 6 months.
In a miopichesky disease parabulbarno on 5 mg of 1 times a day. A course of treatment – 10 days. It is recommended in combination with angioprotektorny means and vitamins of group B.
Drug is dissolved in 1 – 2 ml of water for injections, by 0.9% of solution of sodium of chloride or 0.5% of solution of Procainum (novocaine), directing a needle to a bottle wall in order to avoid foaming.

Side effects
– are possible allergic reactions in case of individual
hypersensitivity to

Contraindication drug components
– individual hypersensitivity to drug components
– children’s and teenage age up to 18 years
– pregnancy and the period of a lactation (there are no data on efficiency and
safety)

Medicinal interactions
Medicinal interaction of drug is not described.

Use special instructions РЕТИНАЛАМИН® only on doctor’s orders!
The bottle with the dissolved medicine cannot be stored and used after storage. RETINALAMIN® solution is not recommended to be mixed with other solutions.
In case of the admission of an injection it is not recommended to enter a double dose, and to carry out the following injection as usual in the planned day.
The lactation period
In need of prescribing of drug in the period of a lactation breastfeeding should be stopped.
Features of influence of medicine on ability to run the vehicle or potentially dangerous mechanisms.
Use of drug does not influence ability to run the vehicle or potentially dangerous mechanisms.

Overdose
About cases of overdose of drug it was not reported.

A form of release and packing
On 22 mg of lyophilisate in the bottles from colourless glass with a capacity of 5 ml according to ISO 8362-1:2009 corked by medical rubber bungs in accordance with GOST of P ISO 8871-5-2010 or traffic jams according to ISO 8362-5:2008 with a running in caps aluminum with a detachable plastic overlay of violet color in accordance with GOST P 51314-99, either according to ISO 8362-6:2010, or according to ISO 8362-7:2006 with a relief inscription GEROPHARM. Apply the self-adhesive label according to industry standard 29.1-2001 on a bottle.
On 5 bottles in blister strip packaging from a film polyvinylchloride in accordance with GOST 25250-88 and aluminum foil in accordance with GOST 745-2003. On the 2nd blister strip packagings together with the instruction for medical use in the state and Russian languages place in packs from cardboard import.
Group packing and a transport container according to GOST 17768-90.

To Store storage conditions in the dry, protected from light place, at a temperature from 2 to 20 of 0C.
To store out of children’s reach.

3 years
not to use a period of storage after an expiration date.

Prescription status
According to the prescription

LLC GEROPHARM Producer,
191119, Russia, St. Petersburg, Zvenigorodskaya St., 9
Ph. (812) 703-79-75 (multichannel),
fax (812) 703-79-76

Owner of the registration certificate
of LLC GEROPHARM,
191119, Russia, St. Petersburg, Zvenigorodskaya St., 9
Ph. (812) 703-79-75 (multichannel),
fax (812) 703-79-76

The address of the organization accepting claims from consumers concerning quality of products in the territory of the Republic of Kazakhstan
Representative office of LLC GEROPHARM in the Republic Kazakhstang. Almaty, Timiryazev St., 42, pavilion 15/108-109, office 339 ph. 8 (727) 334-15-70
In the territory of Russia
LLC GEROPHARM, Russia, located at
address: Russia, 197022, St. Petersburg, Academician Pavlov St., 5B
Ph. (812) 703-79-75 (multichannel), fax (812) 703-79-76
Phone number of hotline: 8-800-333-4376 (toll free in Russia)
www.retinalamin.ru
www.geropharm.ru

Reviews

There are no reviews yet.

Be the first to review “Retinalamin® 5 mg, 10 amps lyophilized powder for intramuscular solution”

Your email address will not be published. Required fields are marked *